Korean Diabetes J.  2009 Dec;33(6):537-546. 10.4093/kdj.2009.33.6.537.

The Status of Diabetes Mellitus and Effects of Related Factors on Heart Rate Variability in a Community

• Chang KS
• Lee K
• Lim HS

• KMID: 2298060
• DOI: http://doi.org/10.4093/kdj.2009.33.6.537

Abstract

BACKGROUND
This study was performed to examine the status of diabetes mellitus (DM) in the community and effects of related factors on heart rate variability (HRV). METHODS: The author conducted HRV testing, a questionnaire survey, and blood chemistry analysis for fasting blood sugar (FBS) and HbA1c levels in 855 patients in a community over a period of 10 days, from August 14 to 25, 2006. The subjects were divided into a DM group and normal group by our study criteria. RESULTS: The proportion of DM was 12.6% and increased with old age. The mean measures of HRV (SDNN, Tp, Vlf, Lf, Hf, Lf/Hf) in the DM group were 22.7 (1.6) msec, 364.9 (2.7) msec2, 174.1 (3.0) msec2, 88.1 (3.2) msec2, 55.3 (3.2) msec2, and 1.6 (2.6), respectively, while those in the normal group were 32.2 (1.6) msec, 676.6 (2.8) msec2, 295.7 (3.1) msec2, 169.2 (3.4) msec2, 117.2 (3.2) msec2, and 1.4 (2.6), respectively. All parameters except for Lf/Hf were significantly lower in the DM group than in the normal group (P < 0.01). The Spearman's correlation coefficients between HRV and FBS or HbA1c were SDNN -0.222/-0.244 (P < 0.01), Tp -0.211/-0.212 (P < 0.01), Vlf -0.149/-0.132 (P < 0.01), Lf -0.188/-0.235 (P < 0.01), Hf -0.207/-0.204 (P < 0.01), and Lf/Hf (P > 0.05), respectively. CONCLUSION: This study shows that the DM group had a reduced HRV and increased pulse rate in comparison with the normal group. According to our results, the HRV test may be used accessorily for the early detection of cardiovascular autonomic neuropathy (CAN) and its related factors, as well as to prevent CAN.

Keyword

Diabetes mellitus; Diabetic neuropathies; Heart rate; Risk factors

MeSH Terms

Blood Glucose
Diabetes Mellitus
Diabetic Neuropathies
Fasting
Heart
Heart Rate
Humans
Risk Factors
Surveys and Questionnaires
Blood Glucose

Figure

• 

  Fig. 1 The flow chart of this study.

Reference

1. Korea National Statistical Office. 2007 annual report on the cause of death statistics. 2008. Daejeon: Korea National Statistical Office.

2. Ministry for Health, Welfare and Family Affairs. Korea Centers for Disease Control and Prevention. The 4th national health and nutrition examination survey. 2009. Seoul: Korea Centers for Disease Control and Prevention.

3. Ko SH, Kwon HS, Lee JM, Kim SR, Cho JH, Yoo KD, Park YM, Lee WC, Song KH, Yoon KH, Cha BY, Son HY, Ahn YB. Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. J Korean Diabetes Assoc. 2006. 30:226–235.

4. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998. 339:229–234.

5. Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 2002. 8:131–138.

6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993. 329:977–986.

7. Nicolucci A, Cavaliere D, Scorpiglione N, Carinci F, Capani F, Tognoni G, Benedetti MM. A comprehensive assessment of the avoidability of long-term complications of diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration. Diabetes Care. 1996. 19:927–933.

8. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with diabetes (UKPDS 34). Lancet. 1998. 352:854–865.

9. Yu JM. Diabetic Autonomic Neuropathy. Diabetes Monit. 2005. 6:7–15.

10. Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003. 23:365–372.

11. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005. 28:956–962.

12. Cho YK, Lee SW, Seo WT, Choi YS, Kang JH, Lee MH, Lee SJ. QTc interval QT dispersion prolongation in NIDDM patients with diabetic autonomic neuropathy. J Korean Diabetes Assoc. 1998. 22:93–102.

13. Yoon JS, Won KC, Lee HW. The relation of QTc dispersion and cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. J Korean Diabetes Assoc. 1998. 22:410–418.

14. Rho YH, Kim NH, Kim DL, Shin DH, Kim SG, Choi KM, Song WH, Baik SH, Seo WK, Park MK, Choi DS. Detection of diabetic autonomic neuropathy by 24-hour heart rate variability analysis in type 2 diabetes mellitus patients. J Korean Diabetes Assoc. 2002. 26:208–219.

15. Jeong KS. The outline of HRV. J Korean Acad Fam Med. 2004. 25:S528–S532.

16. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (TFESC and NASPE). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996. 93:1043–1065.

17. Choi WS, Ock SM, Kim CM, Lee BC, Jeong KS, Lee SJ. Effects of aerobic exercise on heart rate variability (HRV). J Korean Acad Fam Med. 2005. 26:561–566.

18. Lim HS. The final report on monitoring of exposure levels and biomarker of environmental pollutants for industrial residents (Pohang, 1st Year). 2007. Incheon: Ministry of Environment; National Institute of Environmental Research.

19. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002. 25:suppl 1. S33–S49.

20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003. 26:suppl 1. S5–S20.

21. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004. 19:1175–1180.

22. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care. 2007. 30:2233–2235.

23. Park SK, Kim JS. The estimation of prevalence of diabetes mellitus in a rural adult population. Korean J Prev Med. 1996. 29:483–494.

24. Kardelen F, Akcurin G, Ertug H, Akcurin S, Bircan I. Heart rate variability and circadian variations in type 1 diabetes mellitus. Pediatr Diabetes. 2006. 7:45–50.

25. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev. 1994. 10:339–383.

26. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2004. 25:363–370.

27. Gottsäter A, Ahlgren AR, Taimour S, Sundkvist G. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res. 2006. 16:228–234.

28. Son M, Sung J, Yum M, Kong JO, Lee HU, Kim IA, Kim JY. Circardian disruptions of heart rate variability among weekly consecutive-12-hour 2 shift workers in the automobile factory in Korea. J Prev Med Public Health. 2004. 37:182–189.

29. Spallone V, Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in Diabetes. Diabetes. 1997. 46:suppl 2. S67–S76.

30. Kim JS, Choi SB, Kang KK, Song KW, Kim KH, Lee YW. Observation of methods estimating autonomic nervous control of the heart in patients with diabetes. Korean J Med. 1980. 23:1136–1143.

31. CHO CG. Assessment of diabetic autonomic neuropathy. Diabetes Monit. 2000. 1:143–150.

32. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care. 2001. 24:1793–1798.

33. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Determinants of heart rate variability. J Am Coll Cardiol. 1996. 28:1539–1546.

34. Hayano J, Yamada M, Sakakibara Y, Fujinami T, Yokoyama K, Watanabe Y, Takata K. Short- and long-term effects of cigarette smoking on heart rate variability. Am J Cardiol. 1990. 65:84–88.

35. Masters JA, Stevenson JS, Schaal SF. The association between moderate drinking and heart rate variability in healthy community-dwelling older women. Biol Res Nurs. 2004. 5:222–233.

36. Janszky I, Ericson M, Blom M, Georgiades A, Magnusson JO, Alinagizadeh H, Ahnve S. Wine drinking is associated with increased heart rate variability in women with coronary heart disease. Heart. 2005. 91:314–318.

37. Loimaala A, Huikuri H, Oja P, Pasanen M, Vuori I. Controlled 5-mo aerobic training improves heart rate but not heart rate variability or baroreflex sensitivity. J Appl Physiol. 2000. 89:1825–1829.

38. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation. 2003. 107:2190–2195.

39. Benthem L, Keizer K, Wiegman CH, de Boer SF, Strubbe JH, Steffens AB, Kuipers F, Scheurink AJ. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab. 2000. 279:E1286–E1293.